Delivery Order SPE2DB20D3103-SPE2DB24FN6W7

Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) and is valued at $1,606.03. The contract is for Tretinoin 0.025% Cream, a pharmaceutical product, with a period of performance through September 27, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Tretinoin 0.05% Cream 20GM medical products to the Defense Logistics Agency (DLA). The $1,555.43 firm fixed-price delivery order contract has a period of performance through March 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,305.06 firm fixed-price delivery order is for the supply of TRETINOIN 0.1% CREAM 45GM, a pharmaceutical product. The contract has an ultimate completion date of January 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Tretinoin 0.05% Cream in 45 gram quantities. The Firm Fixed Price delivery order, valued at $1,179.60, has an ultimate completion date of July 26, 2022. The contract was awarded on July 25, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp. by the Defense Logistics Agency (DLA) is for the delivery of Tretinoin 0.1% Cream in 45 gram quantities. The award, valued at $2,018.17, is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 12, 2022. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tretinoin 0.05% Cream in 45 gram units, with a firm fixed price of $1,007.37 and a completion date of September 10, 2024. The contract is a Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of TRETINOIN 0.025% CREAM 45GM. The $1,569.78 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 10, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,653.49 issued under the Defense Logistics Agency's (DLA) Indefinite Delivery Contract (IDC) SPE2DB25FMAUA. The contract is for the supply of Tretinoin 0.05% Cream, a pharmaceutical product used in various medical treatments. The award has an ultimate completion date of October 18, 2024 and is a Firm Fixed Price contract. No set-aside designation was used for this award. As a major pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order is for Tretinoin 0.025% Cream, a medical product, with a ceiling value of $11,947.48 and a period of performance through September 20, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
The federal contract award is for the delivery of Tretinoin 0.025% cream, 45 grams, to the Defense Logistics Agency (DLA). The contract, valued at $1,434.81, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 28, 2023. The contract is not designated with any set-aside requirements, indicating open competition....
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FN6W7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,976.59 Firm Fixed Price Delivery Order covers the supply of Tretinoin 0.05% Cream, 45 grams, a pharmaceutical product. The contract has an ultimate completion date of May 6, 2024.

Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:15 PM